Buckwheat phenolic metabolites in health and disease.
Level 5 - mechanism / opinion, no new human data
Narrative review aggregating in vitro, animal, and clinical literature without systematic review methodology
PubMed 27046048 · doi:10.1017/S0954422415000190
What was done
This narrative review synthesized published in vitro experiments, preclinical studies, and clinical trials examining the physiological and health effects of buckwheat (Fagopyrum esculentum Moench and F. tataricum Gaertner) groats, flour, herbs, and phenolic metabolites such as rutin and quercetin.
What was found
The abstract reports no quantitative metrics, effect sizes, or statistical values. It qualitatively summarizes evidence indicating that buckwheat and its metabolites exhibit antioxidative, cytotoxic, and antigenotoxic properties, alongside suggested improvements in blood pressure, lipid profiles, weight regulation, postprandial glucose, insulin responses, insulin signalling preservation, and potential applications in Alzheimer's disease.
Why it matters
The paper maps the broad spectrum of proposed nutritional and therapeutic applications of buckwheat phenolics across metabolic, cardiovascular, and neurological domains.
Limits
No quantitative findings, sample sizes, or study counts are reported in the abstract. The synthesis is a non-systematic narrative review aggregating heterogeneous in vitro, animal, and human data without systematic quality appraisal, preventing firm clinical conclusions.
Cited by
- supports Himalayan Tartary buckwheat contains over 100 immune-active polyphenols, including quercetin and rutin.